Adding to this, because subjects with obesity exhibit lower ClpB levels [12], contributing to obesity-related metabolic dysfunction, it is important to assess Hafnia alvei HA4597TM supplementation in ClpB production on this target group. This evidence concerns the gene CLPB and obesity due to melanocortin 4 receptor deficiency.